Pfizer vaccines head Kathrin Jansen to retire this year
She previously led vaccine research at vaccines and health care products maker Wyeth, which was acquired by Pfizer over a decade ago.
New Delhi: Pfizer Inc's vaccines head Kathrin Jansen, who led the development of the U.S. drugmaker's COVID-19 shot, has decided to retire later this year."Over the last two years, Kathrin's legendary resolve, stellar scientific intuition, and vaccine development expertise ushered in the first glimmer of hope for humanity in the middle of the pandemic," Chief Scientific Officer Mikael...
Login or Register to read the full article
New Delhi: Pfizer Inc's vaccines head Kathrin Jansen, who led the development of the U.S. drugmaker's COVID-19 shot, has decided to retire later this year.
"Over the last two years, Kathrin's legendary resolve, stellar scientific intuition, and vaccine development expertise ushered in the first glimmer of hope for humanity in the middle of the pandemic," Chief Scientific Officer Mikael Dolsten said in a LinkedIn post announcing the retirement.
Pfizer developed the two-dose shot in collaboration with Germany's BioNTech. The vaccine became available in the United States under an emergency use authorization in late 2020 and is now the Western world's most widely used COVID-19 shot.
Jansen, who became the senior vice president of vaccine research and development in 2015, had been the chief scientific officer of the drugmaker's vaccine research and early development research unit.
She previously led vaccine research at vaccines and health care products maker Wyeth, which was acquired by Pfizer over a decade ago.
When contacted, Pfizer pointed to the LinkedIn post by Dolsten without providing additional comment.
Read also: Pfizer seeks USFDA emergency use nod for COVID booster in children aged 5 through 11 years
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd